Showing 3261-3270 of 5972 results for "".
- Judge Blocks Launch of Xeomin for Aesthetic Indicationshttps://practicaldermatology.com/news/20120307-judge_blocks_launch_of_xeomin_for_aesthetic_indications/2459852/The planned March 12 launch of Merz's Xeomin (incobotulinumtoxinA) for aesthetic indications will almost certainly be delayed due to a court order blocking marketing of incobotulinumtoxinA. The order comes in response to a suit by
- Tina Alster, MD Introduces LipoSonix to DC Areahttps://practicaldermatology.com/news/20120229-tina_alter_md_introduces_liposonix_to_dc_area/2459858/LipoSonix is now available at the Washington Institute of Dermatologic Laser Surgery for patients interested in reducing fat through body contouring. Tina Alster, MD provides treatments with The LipoSonix system, an FDA-cleared device that uses high inte
- National Academy of Dermatology Nurse Practitioners Inaugural Conference in Mayhttps://practicaldermatology.com/news/20120224-national_academy_of_dermatology_nurse_practitioners__inaugural_conference_in_may/2459865/The inaugural conference of the National Academy of Dermatology Nurse Practitioners will be held May 2-5, 2012 in Clearwater Beach, FL at the Sheraton Sand Key Resort. Designed for all nurse practitioners regardless of experience or practice seting, the program covers both medical and aesthetic derm
- Polypharmacy Issues in Older Patients Concerning but Improvinghttps://practicaldermatology.com/news/Polypharmacy-Issues-Older-Patients-Concerning-Improving/2474817/Geriatric medicine hinges on eight guiding principles, Freba Farhat, MD, said at the ElderDerm 2025 Conference in Washington, DC: life expectancy, multimorbidity, functional status, cognition, mobility, social support, patient preference, and polypharmacy. The last of those factors can sometimes
- Obesity and Epidermal Innate Immunity Linked to Resistance to Biologic Therapy in Psoriasishttps://practicaldermatology.com/news/obesity-and-epidermal-innate-immunity-linked-to-resistance-to-biologic-therapy-in-psoriasis/2473927/Patients with severe plaque psoriasis who are overweight are more likely to experience resistance to biologic therapies, according to new findings The study researchers designed and conducted a cross-sectional study at Gachon
- New Spesolimab Data Indicate Impact on Both Physical, Mental Healthhttps://practicaldermatology.com/news/New-Spesolimab-Data-Indicate-Impact-Both-Physical-Mental-Health/2471581/New analyses of the effects of spesolimab on the physical symptoms and mental health burden associated with generalized pustular psoriasis (GPP) were presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida. These post-hoc exploratory analyses from the
- TSC Reduces Tretinoin-Induced Skin Irritation: Pilot Studyhttps://practicaldermatology.com/news/tsc-reduces-tretinoin-induced-skin-irritation-pilot-study/2471409/A recent pilot study has shown that tetramethylhexadecenyl succinoyl cysteine (TSC) significantly reduces erythema and dryness caused by tretinoin application. These findings may offer a novel approach to minimizing the common adverse effects of tretinoin, potential
- Beyond the Surface: Updates in Itch Treatmenthttps://practicaldermatology.com/news/beyond-the-surface-updates-in-itch-treatment/2471285/
- Study IDs Proteins Associated With Inflammatory Mechanisms of Psoriasishttps://practicaldermatology.com/news/study-ids-proteins-associated-inflammatory-mechanisms-psoriasis/2470870/A comparative analysis of dermal mesenchymal stem cell exosomes from healthy human skin and psoriatic lesions revealed 13 differential proteins, according a research published in Current Molecular Medicine. Researchers at Shanxi Medical University published “Proteomic Analysis of Mesenchym
- National Rosacea Society Introduces Informational Postcardhttps://practicaldermatology.com/news/national-rosacea-society-introduces-informational-postcard/2470763/The National Rosacea Society (NRS) announced today that it has released a new educational postcard to raise awareness about rosacea, a chronic skin condition affecting over 16 million Americans. Titled “Rosacea: A Common Disease, Uncommonly Treated,” the resource is designed for d